FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229331844> ?p ?o ?g. }

• W4229331844 endingPage "103708" @default.
• W4229331844 startingPage "103708" @default.
• W4229331844 abstract "Policies to address opioid-related harms include strategies to reduce opioid prescribing for new and ongoing pain management. Concerns have been raised that people with chronic non-cancer pain (CNCP) may be adversely affected by prescribing restrictions, and by involuntary tapering and cessation of opioids. We describe self-reported challenges obtaining prescription opioids among people prescribed opioids long-term for CNCP and explore associations with participant and treatment characteristics. This cross-sectional study analysed data from a longitudinal cohort study of Australians prescribed restricted opioids for CNCP. In 2018, 861 participants who took part in Year 5 follow-up and who also reported past 12-month opioid use were asked about challenges obtaining opioid prescriptions, including prescriber access-related difficulties obtaining prescriptions or having opioids tapered or ceased involuntarily. Associations between challenges and demographics, treatment characteristics including daily opioid dose as oral morphine equivalent milligrams (OME mg/day), substance use disorder (SUD), and opioid dependence were assessed. Overall, 285 (31%) participants reported at least one challenge, predominantly prescriber access-related difficulties (n=177/285; 62%). Prescriber access-related difficulties were associated with younger age (adjustedOR 0.94 per year increase, 95%CI 0.93-0.96), and past 12-month pharmaceutical opioid dependence (adjustedOR 2.25, 95%CI 1.33-3.80). Involuntary opioid tapering or cessation was reported by 73 participants (26% of those reporting challenges) and was associated with lifetime SUD diagnosis (adjustedOR 2.15, 95%CI 1.15-3.90), and opioid doses of ≥200 OME mg/day (adjustedOR 2.41, 95%CI 1.18-4.88). One-third of participants with CNCP reported experiencing challenges obtaining prescriptions for opioids or having their opioid medicines involuntarily reduced. Given increasing restrictions to opioid access, it is important that strategies to reduce opioid-related harms are balanced against the current treatment needs of people prescribed opioids long-term for CNCP." @default.
• W4229331844 created "2022-05-09" @default.
• W4229331844 creator A5004258113 @default.
• W4229331844 creator A5004809640 @default.
• W4229331844 creator A5007290128 @default.
• W4229331844 creator A5032225981 @default.
• W4229331844 creator A5052675833 @default.
• W4229331844 creator A5060125444 @default.
• W4229331844 creator A5076740440 @default.
• W4229331844 date "2022-07-01" @default.
• W4229331844 modified "2023-09-29" @default.
• W4229331844 title "Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain" @default.
• W4229331844 cites W1841442816 @default.
• W4229331844 cites W1929010380 @default.
• W4229331844 cites W1951588231 @default.
• W4229331844 cites W1965999023 @default.
• W4229331844 cites W1974874432 @default.
• W4229331844 cites W1986692293 @default.
• W4229331844 cites W1990661122 @default.
• W4229331844 cites W2024012275 @default.
• W4229331844 cites W2044783221 @default.
• W4229331844 cites W2050287964 @default.
• W4229331844 cites W2090562839 @default.
• W4229331844 cites W2101940977 @default.
• W4229331844 cites W2168959959 @default.
• W4229331844 cites W2172877084 @default.
• W4229331844 cites W2233361447 @default.
• W4229331844 cites W2296986887 @default.
• W4229331844 cites W2297937587 @default.
• W4229331844 cites W2333420310 @default.
• W4229331844 cites W2462703180 @default.
• W4229331844 cites W2581923668 @default.
• W4229331844 cites W2586047144 @default.
• W4229331844 cites W2606685268 @default.
• W4229331844 cites W2724541579 @default.
• W4229331844 cites W2745670698 @default.
• W4229331844 cites W2765285001 @default.
• W4229331844 cites W2769581225 @default.
• W4229331844 cites W2805664586 @default.
• W4229331844 cites W2887567084 @default.
• W4229331844 cites W2893992800 @default.
• W4229331844 cites W2895896590 @default.
• W4229331844 cites W2905788968 @default.
• W4229331844 cites W2911840920 @default.
• W4229331844 cites W2941323238 @default.
• W4229331844 cites W2960567281 @default.
• W4229331844 cites W2969233749 @default.
• W4229331844 cites W2970745849 @default.
• W4229331844 cites W2982644934 @default.
• W4229331844 cites W2989723645 @default.
• W4229331844 cites W2989888278 @default.
• W4229331844 cites W2991316506 @default.
• W4229331844 cites W2995253342 @default.
• W4229331844 cites W3008630140 @default.
• W4229331844 cites W3049184494 @default.
• W4229331844 cites W3089575752 @default.
• W4229331844 cites W3097784235 @default.
• W4229331844 cites W3119540740 @default.
• W4229331844 cites W3128678812 @default.
• W4229331844 cites W3137016091 @default.
• W4229331844 cites W3144159824 @default.
• W4229331844 cites W3149625902 @default.
• W4229331844 cites W3155748587 @default.
• W4229331844 cites W3159687605 @default.
• W4229331844 cites W3171461065 @default.
• W4229331844 cites W3191363542 @default.
• W4229331844 cites W3200346922 @default.
• W4229331844 cites W4237886572 @default.
• W4229331844 doi "https://doi.org/10.1016/j.drugpo.2022.103708" @default.
• W4229331844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35544972" @default.
• W4229331844 hasPublicationYear "2022" @default.
• W4229331844 type Work @default.
• W4229331844 citedByCount "2" @default.
• W4229331844 countsByYear W42293318442023 @default.
• W4229331844 crossrefType "journal-article" @default.
• W4229331844 hasAuthorship W4229331844A5004258113 @default.
• W4229331844 hasAuthorship W4229331844A5004809640 @default.
• W4229331844 hasAuthorship W4229331844A5007290128 @default.
• W4229331844 hasAuthorship W4229331844A5032225981 @default.
• W4229331844 hasAuthorship W4229331844A5052675833 @default.
• W4229331844 hasAuthorship W4229331844A5060125444 @default.
• W4229331844 hasAuthorship W4229331844A5076740440 @default.
• W4229331844 hasConcept C118552586 @default.
• W4229331844 hasConcept C126322002 @default.
• W4229331844 hasConcept C170493617 @default.
• W4229331844 hasConcept C2426938 @default.
• W4229331844 hasConcept C2778722691 @default.
• W4229331844 hasConcept C2779418921 @default.
• W4229331844 hasConcept C2781063702 @default.
• W4229331844 hasConcept C2781118164 @default.
• W4229331844 hasConcept C42219234 @default.
• W4229331844 hasConcept C71924100 @default.
• W4229331844 hasConcept C72563966 @default.
• W4229331844 hasConcept C98274493 @default.
• W4229331844 hasConceptScore W4229331844C118552586 @default.
• W4229331844 hasConceptScore W4229331844C126322002 @default.
• W4229331844 hasConceptScore W4229331844C170493617 @default.
• W4229331844 hasConceptScore W4229331844C2426938 @default.

• next